Table 1 Comparisons of baseline LC and LWR values and clinicopathological features in cohort 1 (N = 378)
Clinicopathological features | n | LC M (P 25 ~ P 75) | P | LWR M (P 25 ~ P 75) | P |
|---|---|---|---|---|---|
Age (M (P 25 ~ P 75)) | 64(56 ~ 73) | -- | -- | ||
Gender | 0.751 | 0.019 | |||
Male | 209(55.29%) | 0.8(1.1 ~ 1.5) | 0.081(0.133 ~ 0.194) | ||
Female | 169(44.71%) | 0.8(1.1 ~ 1.5) | 0.095(0.145 ~ 0.222) | ||
Tumor stage | 0.586 | 0.058 | |||
III | 23(6.08%) | 0.9(1.2 ~ 1.5) | 0.127(0.190 ~ 0.214) | ||
IV | 355(93.92%) | 0.8(1.1 ~ 1.5) | 0.084(0.136 ~ 0.207) | ||
Primary tumor site | 0.110 | 0.308 | |||
Gastrointestinal tumors | 198(52.38%) | 0.7(1 ~ 1.4) | 0.081(0.131 ~ 0.190) | ||
Thoracic cancer | 86(22.75%) | 0.9(1.2 ~ 1.7) | 0.092(0.142 ~ 0.213) | ||
Urogenital neoplasms | 59(15.61%) | 0.8(1.1 ~ 1.6) | 0.088(0.147 ~ 0.235) | ||
Head and neck neoplasm | 16(4.23%) | 0.8(1.1 ~ 1.4) | 0.089(0.137 ~ 0.246) | ||
Other tumors | 19(5.03%) | 0.9(1.3 ~ 1.6) | 0.099(0.171 ~ 0.245) | ||
Family history | 0.935 | 0.999 | |||
No | 264(70.78%) | 0.8(1.1 ~ 1.5) | 0.083(0.141 ~ 0.203) | ||
Yes | 109(29.22%) | 0.8(1.1 ~ 1.5) | 0.091(0.127 ~ 0.222) | ||
Unknown | 5 | ||||
Smoking history | 0.478 | 0.005 | |||
No | 265(71.62%) | 0.8(1.1 ~ 1.5) | 0.092(0.145 ~ 0.214) | ||
Yes | 105(28.38%) | 0.8(1 ~ 1.5) | 0.075(0.118 ~ 0.185) | ||
Unknown | 8 | ||||
ECOG | 0.564 | <0.001 | |||
< 3 | 218(57.67%) | 0.8(1.1 ~ 1.5) | 0.094(0.146 ~ 0.231) | ||
> =3 | 160(42.33%) | 0.8(1.1 ~ 1.5) | 0.072(0.113 ~ 0.173) | ||
Concomitant disease | 0.440 | 0.968 | |||
No | 229(60.58%) | 0.8(1.1 ~ 1.5) | 0.085(0.138 ~ 0.214) | ||
Yes | 149(39.42%) | 0.8(1.1 ~ 1.6) | 0.088(0.139 ~ 0.198) | ||
Nutrient status | 0.012 | <0.001 | |||
Normal | 107(28.50%) | 0.8(1.2 ~ 1.6) | 0.108(0.169 ~ 0.233) | ||
Abnormal | 268(71.50%) | 0.8(1 ~ 1.45) | 0.079(0.129 ~ 0.196) | ||
Unknown | 3 |